Psoriasis and side-effects of mesotherapy.
Rosina
P
P
Section of Dermatology and Venereology, Department of Biomedical and Surgical Sciences, University of Verona, Italy. prosina@yahoo.com
Chieregato
C
C
Miccolis
D
D
D'Onghia
F S
FS
D000368:Aged; D000628:Aminophylline / Q000008:administration & dosage / Q000009:adverse effects*; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects*; D016572:Cyclosporine / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007271:Injections, Intradermal / Q000009:adverse effects; D008012:Lidocaine / Q000008:administration & dosage / Q000009:adverse effects*; D011565:Psoriasis / Q000188:drug therapy / Q000473:pathology*; D012585:Sciatica / Q000188:drug therapy; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects*; D014971:Xanthinol Niacinate / Q000008:administration & dosage / Q000009:adverse effects*
D000779:Anesthetics, Local; D003879:Dermatologic Agents; D014665:Vasodilator Agents; D000628:Aminophylline; D016572:Cyclosporine; D014971:Xanthinol Niacinate; D008012:Lidocaine